It is well known that myo-inositol (MI) and D-chiro-inositol (DCI) are insulin-sensitizing agents, and MI is of proven utility in polycystic ovary syndrome (PCOS). In addition, MI plays a pivotal role in the physiology of reproduction, and has beneficial effects on the development of oocytes, spermatozoa, and embryos. By contrast, DCI has little effect on spermatozoa, but high concentrations in the ovary can negatively affect the quality of oocytes and the blastocyst. Overall, the evidence in the literature supports the beneficial effects of MI in both female and male reproduction, warranting clinical use of MI in assisted reproductive treatment (ART).

Breakthroughs in the use of inositols for Assisted Reproductive Treatment (ART) / Facchinetti, F.; Espinola, M. S. B.; Dewailly, D.; Ozay, A. C.; Prapas, N.; Vazquez-Levin, M.; Wdowiak, A.; Unfer, V.; Appetecchia, M.; Aragona, C.; Bertelli, M.; Bevilacqua, A.; Bizzarri, M.; Cavalli, P.; Copp, A.; D'Anna, R.; Greene, N.; Marin, I. H.; Kamenov, Z. A.; Kandaraki, E.; Diamanti-Kandarakis, E.; Lagana, A. S.; Monastra, G.; Oliva, M. M.; Nestler, J. E.; Papalou, O.; Pkhaladze, L.; Porcaro, G.; Soulage, C. O.; Stringaro, A.. - In: TRENDS IN ENDOCRINOLOGY AND METABOLISM. - ISSN 1043-2760. - 31:8(2020), pp. 570-579. [10.1016/j.tem.2020.04.003]

Breakthroughs in the use of inositols for Assisted Reproductive Treatment (ART)

Aragona C.;Bevilacqua A.;Bizzarri M.;
2020

Abstract

It is well known that myo-inositol (MI) and D-chiro-inositol (DCI) are insulin-sensitizing agents, and MI is of proven utility in polycystic ovary syndrome (PCOS). In addition, MI plays a pivotal role in the physiology of reproduction, and has beneficial effects on the development of oocytes, spermatozoa, and embryos. By contrast, DCI has little effect on spermatozoa, but high concentrations in the ovary can negatively affect the quality of oocytes and the blastocyst. Overall, the evidence in the literature supports the beneficial effects of MI in both female and male reproduction, warranting clinical use of MI in assisted reproductive treatment (ART).
2020
assisted reproductive treatment; d-chiro-inositol; polycystic ovary syndrome; in vitro fertilization; infertility; myo-inositol
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Breakthroughs in the use of inositols for Assisted Reproductive Treatment (ART) / Facchinetti, F.; Espinola, M. S. B.; Dewailly, D.; Ozay, A. C.; Prapas, N.; Vazquez-Levin, M.; Wdowiak, A.; Unfer, V.; Appetecchia, M.; Aragona, C.; Bertelli, M.; Bevilacqua, A.; Bizzarri, M.; Cavalli, P.; Copp, A.; D'Anna, R.; Greene, N.; Marin, I. H.; Kamenov, Z. A.; Kandaraki, E.; Diamanti-Kandarakis, E.; Lagana, A. S.; Monastra, G.; Oliva, M. M.; Nestler, J. E.; Papalou, O.; Pkhaladze, L.; Porcaro, G.; Soulage, C. O.; Stringaro, A.. - In: TRENDS IN ENDOCRINOLOGY AND METABOLISM. - ISSN 1043-2760. - 31:8(2020), pp. 570-579. [10.1016/j.tem.2020.04.003]
File allegati a questo prodotto
File Dimensione Formato  
Facchinetti_ART_2020.pdf

solo gestori archivio

Note: https://www.sciencedirect.com/science/article/abs/pii/S1043276020300801
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.61 MB
Formato Adobe PDF
1.61 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1504656
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 32
social impact